logo
  

EC Approves Sanofi's Aubagio For Treatment Of Pediatric Patients With RRMS

French drug maker Sanofi (SNY) said that the European Commission has approved Aubagio or teriflunomide for the treatment of pediatric patients 10 to 17 years of age with relapsing-remitting multiple sclerosis or RRMS.

The approval was based on data from the Phase 3 TERIKIDS study. The approval confirmed Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European Union.

Aubagio was initially approved in the EU in 2013 for the treatment of adult patients with RRMS and the EC approval for the pediatric indication provides an additional year of marketing protection in the European Union.

Multiple sclerosis is a chronic neurodegenerative disease in which a person's immune system causes damage to the brain and spinal cord.

Last week, the U.S. Food and Drug Administration had rejected an application requesting the expansion of Aubagio for the treatment of children and adolescents, ages 10 to 17, with relapsing forms of multiple sclerosis.

The FDA deemed the data submitted were not sufficient to obtain approval of an indication in the pediatric population at this time. The FDA updated the Aubagio label to include safety data from the pediatric clinical trial program. The indicated use of Aubagio in patients 18 years and older remains unchanged, Sanofi said in a press release last week.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Velvet Ice Cream recalled certain lots of its 56 oz Raspberry Fudge Cordial Ice Cream for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was notified of the issue by a single customer and has since learned that the cause of the error has been traced to a third-party manufacturer packaging error. Willard, Ohio-based Buurma Farms Inc. is recalling 320 boxes of its Plain Parsley citing possible contamination with Shiga-toxin producing E.coli, the U.S. Food and Drug Administration said. The recall involves Buurma Plain (flat leaf) Parsley with a harvest date of August 30, 2021 from their Gregory, Michigan location. Molson Coors Beverage Co. is bringing Topo Chico Hard Seltzer, the sparkling mineral water, across the United States starting January 2022. The company will officially expand the distribution of the product, which was launched last spring in nine states and seven metro areas, to all 50 states. Molson Coors is manufacturing, marketing and distributing Topo Chico Hard Seltzer in the U.S.
Follow RTT